In a previous post, we answered if a medical device design and development plan is a regulatory requirement? As a continuation of that post, this week we are exploring what structure the top-level plan should follow. Alongside the flowchart and other documentation, you will be writing the top-level plan. This too will be a live document that you will be writing alongside your flow chart, Gantt chart, and other supporting documentation. Essentially, this is the launchpad to those other documents and so you would list them as external references.
So, this is the high-level master document that executives can read to understand how much the project is going to cost, how long it’s going to take, and ultimately, if it will be feasible. Typically, a pharmaceutical company will take this document and process it through its financial system to govern the financials, understand the return on investment and market share before deciding whether to progress and plan it into the budget for the next financial year.
There’s an art to writing these documents and remaining concise…
1. Overview:
An overview of the project and its purpose.
2. Scope:
The intended use of the device.
3. Major deliverables
The outputs and deliverables for the project.
4. Exclusions:
These are important to outline from the offset.
5. Assumptions:
It’s fine to make assumptions if everybody involved knows what areas your assumptions lie in. This allows you to evaluate what assumptions were incorrect and spot deviations to recoup some budget when problems arise.
6. Project team/structure:
This gives an idea of who’s working on the project, how big the team is and how the team works together. This is crucial in multi-disciplinary teams or where external subcontractors are involved.
The plan needs to clearly demonstrate who is responsible for what as well as the relationships between stakeholders. This will help prevent finger-pointing when challenges arise.
7. Required resources:
These include the external resources you will require such as your test houses, manufacturers, and validation Partners.
8. Accreditation, documentation, procedures & necessary competencies:
This will demonstrate that you have the right certifications, procedures and a robust QMS system in place.
9. Flow Chart Outputs:
These get migrated into a Gantt chart where you will list all line items and start assigning time and cost to each item. This is where the research as well as discussions with your identified resources will happen to gain costs, timeframes, and other parameters to build into the Gantt chart. The results from the flow and Gantt chart work will usually be distilled into a list of major milestones including information such as who’s responsible for these milestones and, when these milestones will be delivered.
Technical Director
John represents regulatory affairs on the board. He manages our quality management system, as well as ensuring tools and systems are in place for the teams to effectively perform.
John holds a Bachelor’s Degree in Industrial and Product Design along with over 15 years’ experience in medical device development. John has particular expertise in the design, development and industrialisation of medical electrical equipment.
Get In Touch
Discover how Haughton Design's diverse team leverages their extensive experience to drive innovation in device development. Learn about our expertise and unique insights that ensure successful project...
Explore how commercial constraints influence innovation in businesses. Discover whether budget limits, regulations, and market pressures drive creativity or stifle progress in today's competitive land...
HD strive to foster effective collaboration on all projects to push boundaries in innovation. We discuss how collaboration with the NHS can provide unique insight....
Why do we trust the accuracy of digital devices more than their non-digital counterparts? HD discuss the 'why' and how this improves device development....
We discuss the whether the medical device industry can embrace paper as a viable alternative to plastic as we advance towards Net Zero....
What is the impact of emerging technologies on medical device and product development? Design Engineer, Dan Kirkham, discusses their applications....
We discuss transforming medical device development through the utilisation of interdisciplinary, and cross industry teams....
A pharmaceutical company approached HD to enhance the performance and improve the usability of a Dry Powder Inhaler within a short timeframe and, a tight budget. ...
Pharmapack 2024 was a captivating blend of innovation, collaboration, and foresight. Read our round up of the eco-focused event here....
2023's DDL event brought together industry experts in the field of respiratory health. Here we discuss the latest breakthroughs and innovations....
Should Human Factors as a standalone discipline be made redundant? Design Engineer, Elena, considers this for medical device development?...
Can we achieve the perfect balance of usability, sustainability & connectivity in medical device design? Design Engineer, Rob, considers how....
2023's PDA & PODD conferences provided valuable insight into the drug delivery industry. Here we discuss trends and hot topics from the conferences....
Ahead of the 20th PDA Universe of Pre-Filled Syringes and Injection Devices Conference, we cover where medical device innovations are expected to go....
As the world becomes increasingly connected and user needs constantly evolving, the design of safety critical IFU’s must keep up with this. Design Engineer, Rob, discusses the future of IFU’s, and...
With the speed at which the medical device world is changing, collaborative partnerships will be essential for success. HD discuss the benefits....
